Mizuho Securities USA’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Sell
22,713
-4,644
-17% -$2.52M 0.26% 74
2025
Q4
$16.2M Sell
27,357
-146
-0.5% -$82.6K 0.27% 49
2025
Q3
$13.6M Buy
27,503
+1,411
+5% +$657K 0.27% 59
2025
Q2
$10.6M Sell
26,092
-4,535
-15% -$1.9M 0.23% 81
2025
Q1
$15.2M Sell
30,627
-5,625
-16% -$3.05M 0.33% 50
2024
Q4
$18.9M Buy
36,252
+11,482
+46% +$6.31M 0.34% 43
2024
Q3
$15.3M Sell
24,770
-4,658
-16% -$2.76M 0.33% 37
2024
Q2
$16.3M Buy
+29,428
New +$16.9M 0.36% 42
2020
Q3
Sell
-795
Closed -$288K 189
2020
Q2
$288K Buy
+795
New +$266K 0.02% 121
2017
Q3
Sell
-38,700
Closed -$6.75M 227
2017
Q2
$6.75M Buy
+38,700
New +$6.5M 0.35% 16
2015
Q2
Sell
-39,000
Closed -$5.24M 247
2015
Q1
$5.24M Buy
+39,000
New +$5.03M 0.68% 37

Other funds holding TMO

Mizuho Securities USA's TMO Position: Q1 2026 in Review

Mizuho Securities USA reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q1 2026, selling an estimated $2.52M and leaving 22,713 shares worth $11.2M. The position accounts for 0.26% of the portfolio, ranked #74.

Mizuho Securities USA first reported a position in TMO in Q1 2015 and has held it in 11 quarters since. The position peaked at $18.9M in Q4 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Mizuho Securities USA held 22,713 shares of Thermo Fisher Scientific worth $11.2M as of Q1 2026.
  • Mizuho Securities USA sold 4,644 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.52M.
  • Thermo Fisher Scientific made up 0.26% of Mizuho Securities USA's portfolio in Q1 2026, its #74 holding.
  • Mizuho Securities USA first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 11 quarters since.
  • Mizuho Securities USA's Thermo Fisher Scientific position peaked at $18.9M in Q4 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.